At the mass end, cheaper GLP-1 alternatives could expand access and push these behaviour changes far beyond affluent early adopters
Saxenda (liraglutide) Approved uses: Children ages 12-17 with obesity and adults with overweight, obesity, or a weight-related condition Drug type: Once-daily injection Doses: 0.6 mg (starting dose), 1.2 mg, 1.8 mg, 2.4 mg, and 3 mg
Create account Continue with Google By entering this site, I confirm that I am at least 21 years of age and a qualified researcher, and acknowledge that all products and information provided by UNYX Peptides are intended strictly for laboratory research purposes only not for human or animal consumption, and not for therapeutic, clinical, diagnostic, dietary supplementation, dosing, injection, ingestion, or administration use of any kind.
In parallel, they tracked the neurotoxicity of the peptides, and neuronal viability showed a clear dip during the period when the oligomers were most prominent
*see posters for details Start the New Year with a radiant, beautiful you